CVS Health Corp (CVS) reported better-than-expected financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) reached $1.60, surpassing Wall Street's consensus estimate of $1.38 by $0.22. Revenue for the quarter totaled $102.9 billion, exceeding the anticipated $99.8 billion.
The announcement highlights CVS’s operational strength amid evolving market conditions. The company will host its earnings conference call at BMO to discuss these results and provide additional insights into its business performance.
This update provides insight into CVS Health Corp's financial health and operational performance. Exceeding analyst expectations may indicate stronger-than-anticipated business fundamentals. Investors are encouraged to review the full earnings release and listen to management commentary for a complete context on the quarter's performance and future outlook.
Headquartered in Woonsocket, Rhode Island, CVS Health Corp operates across several segments, including Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. With a market capitalization of $99.85 billion and a P/E ratio of 212.91, the company continues to be a significant player in the health care industry. Upcoming earnings are scheduled for April 28, 2026, where EPS is estimated at $2.3835 with expected revenue of $100.9 billion.